BOSTON, MA — (Marketwired) — 05/20/13 — , the medtech industry-s leading provider of strategic partnership and investment conferences, announced today that it will host the investor conference on , at the . There are many emerging companies that are presenting at an IN3 event for the first time, including and .
has developed a magnetic energy-illuminated nanotechnology platform that selectively heats targeted tissue to enhance the efficacy of traditional chemo and radiation therapies. The first application of the Actium Cancer Treatment (ACT) platform is in support of intravesical chemotherapy in the treatment of non-muscle invasive bladder cancer (NMIBC). will be introducing the ACT platform technology for the first time to the healthcare community at IN3 in Boston. “We expect the IN3 event to be a great place to network, where we-ll have the chance to meet not only senior-level decision-makers from the investment community but also from major medtech and pharma companies,” said Tondu.
has developed an entirely novel, early-stage diagnostic eye test for Alzheimer-s disease (AD) to allow treatment before significant neuronal loss and irreversible brain damage occurs. , who orchestrated the first-ever Series A syndicated angel deal in the Northeast, will present the Cognoptix opportunity. “The medtech industry needs great events like IN3 where there-s a critical mass of emerging companies intersecting with serious investors,” added Hartung.
The Investment in Innovation conference will feature presentations by more than 30 early-, mid- and late-stage start-up companies that are seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. The conference also will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought leaders discussing the most pressing issues facing the global device industry in 2013 and beyond. Panel topics will include: ; ; and, In addition, large company/VC meet-and-greets will be held to facilitate interaction between these two influential groups and conference participants. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.
These interviews will be featured post-conference at , to which a link will be provided to participating companies for their unrestricted use; availability of these video interviews will be broadly promulgated within the medtech industry. All one-on-one interviews with presenting-company CEOs will take place at, and during the IN3 Boston conference and be organized by , President of To schedule the free on-camera interviews contact , or call +1-508-359-4005, x108.
This special event will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in Boston should contact at 949-797-7142, or email .
IN3 Medical Device 360 degrees Boston will be held at the . Event co-sponsors to date include , , , , , and . Visit for more information.
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI () has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108